ID HBSAG_HBVD6 Reviewed; 389 AA. AC Q67875; DT 26-FEB-2008, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 08-NOV-2023, entry version 80. DE RecName: Full=Large envelope protein {ECO:0000255|HAMAP-Rule:MF_04075}; DE AltName: Full=L glycoprotein {ECO:0000255|HAMAP-Rule:MF_04075}; DE AltName: Full=L-HBsAg {ECO:0000255|HAMAP-Rule:MF_04075}; DE Short=LHB {ECO:0000255|HAMAP-Rule:MF_04075}; DE AltName: Full=Large S protein {ECO:0000255|HAMAP-Rule:MF_04075}; DE AltName: Full=Large surface protein {ECO:0000255|HAMAP-Rule:MF_04075}; DE AltName: Full=Major surface antigen {ECO:0000255|HAMAP-Rule:MF_04075}; GN Name=S {ECO:0000255|HAMAP-Rule:MF_04075}; OS Hepatitis B virus genotype D subtype ayw (isolate Italy/CI/1992) (HBV-D). OC Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes; OC Blubervirales; Hepadnaviridae; Orthohepadnavirus; Hepatitis B virus; OC hepatitis B virus genotype D. OX NCBI_TaxID=489489; OH NCBI_TaxID=9606; Homo sapiens (Human). OH NCBI_TaxID=9598; Pan troglodytes (Chimpanzee). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Lai M.E., Mazzoleni A.P., Balestrieri A., Melis A., Porru A.; RT "Sequence analysis of HBV genomes isolated from patients with HBsAg RT negative chronic liver disease."; RL Submitted (MAR-1992) to the EMBL/GenBank/DDBJ databases. RN [2] RP REVIEW. RX PubMed=8957666; DOI=10.1159/000150471; RA Bruss V., Gerhardt E., Vieluf K., Wunderlich G.; RT "Functions of the large hepatitis B virus surface protein in viral particle RT morphogenesis."; RL Intervirology 39:23-31(1996). RN [3] RP REVIEW. RX PubMed=9498079; DOI=10.1007/978-1-4615-5383-0_20; RA Block T.M., Lu X., Mehta A., Park J., Blumberg B.S., Dwek R.; RT "Role of glycan processing in hepatitis B virus envelope protein RT trafficking."; RL Adv. Exp. Med. Biol. 435:207-216(1998). RN [4] RP REVIEW. RX PubMed=15567498; DOI=10.1016/j.virusres.2004.08.016; RA Bruss V.; RT "Envelopment of the hepatitis B virus nucleocapsid."; RL Virus Res. 106:199-209(2004). RN [5] RP REVIEW. RX PubMed=16863502; DOI=10.1111/j.1349-7006.2006.00235.x; RA Wang H.C., Huang W., Lai M.D., Su I.J.; RT "Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and RT hepatocarcinogenesis."; RL Cancer Sci. 97:683-688(2006). CC -!- FUNCTION: The large envelope protein exists in two topological CC conformations, one which is termed 'external' or Le-HBsAg and the other CC 'internal' or Li-HBsAg. In its external conformation the protein CC attaches the virus to cell receptors and thereby initiating infection. CC This interaction determines the species specificity and liver tropism. CC This attachment induces virion internalization predominantly through CC caveolin-mediated endocytosis. The large envelope protein also assures CC fusion between virion membrane and endosomal membrane. In its internal CC conformation the protein plays a role in virion morphogenesis and CC mediates the contact with the nucleocapsid like a matrix protein. CC {ECO:0000255|HAMAP-Rule:MF_04075}. CC -!- FUNCTION: The middle envelope protein plays an important role in the CC budding of the virion. It is involved in the induction of budding in a CC nucleocapsid independent way. In this process the majority of envelope CC proteins bud to form subviral lipoprotein particles of 22 nm of CC diameter that do not contain a nucleocapsid. {ECO:0000255|HAMAP- CC Rule:MF_04075}. CC -!- SUBUNIT: Li-HBsAg interacts with capsid protein and with HDV Large CC delta antigen. Isoform M associates with host chaperone CANX through CC its pre-S2 N glycan. This association may be essential for M proper CC secretion. {ECO:0000255|HAMAP-Rule:MF_04075}. CC -!- SUBCELLULAR LOCATION: Virion membrane {ECO:0000255|HAMAP- CC Rule:MF_04075}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing, Alternative initiation; Named isoforms=2; CC Name=L; Synonyms=Large envelope protein, LHB, L-HBsAg; CC IsoId=Q67875-1; Sequence=Displayed; CC Name=S; Synonyms=Small envelope protein, SHB, S-HBsAg; CC IsoId=Q67875-2; Sequence=VSP_031410; CC -!- DOMAIN: The large envelope protein is synthesized with the pre-S region CC at the cytosolic side of the endoplasmic reticulum and, hence will be CC within the virion after budding. Therefore the pre-S region is not N- CC glycosylated. Later a post-translational translocation of N-terminal CC pre-S and TM1 domains occur in about 50% of proteins at the virion CC surface. These molecules change their topology by an unknown mechanism, CC resulting in exposure of pre-S region at virion surface. CC -!- DOMAIN: The large envelope protein is synthesized with the pre-S region CC at the cytosolic side of the endoplasmic reticulum and, hence will be CC within the virion after budding. Therefore the pre-S region is not N- CC glycosylated. Later a post-translational translocation of N-terminal CC pre-S and TM1 domains occur in about 50% of proteins at the virion CC surface. These molecules change their topology by an unknown mechanism, CC resulting in exposure of pre-S region at virion surface. For isoform M CC in contrast, the pre-S2 region is translocated cotranslationally to the CC endoplasmic reticulum lumen and is N-glycosylated. {ECO:0000255|HAMAP- CC Rule:MF_04075}. CC -!- PTM: Isoform M is N-terminally acetylated by host at a ratio of 90%, CC and N-glycosylated by host at the pre-S2 region. {ECO:0000255|HAMAP- CC Rule:MF_04075}. CC -!- PTM: Myristoylated. {ECO:0000255|HAMAP-Rule:MF_04075}. CC -!- BIOTECHNOLOGY: Systematic vaccination of individuals at risk of CC exposure to the virus has been the main method of controlling the CC morbidity and mortality associated with hepatitis B. The first CC hepatitis B vaccine was manufactured by the purification and CC inactivation of HBsAg obtained from the plasma of chronic hepatitis B CC virus carriers. The vaccine is now produced by recombinant DNA CC techniques and expression of the S isoform in yeast cells. The pre-S CC region do not seem to induce strong enough antigenic response. CC -!- SIMILARITY: Belongs to the orthohepadnavirus major surface antigen CC family. {ECO:0000255|HAMAP-Rule:MF_04075}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X65258; CAA46353.1; -; Genomic_DNA. DR PIR; JQ2054; JQ2054. DR PIR; S20749; S20749. DR GlyCosmos; Q67875; 1 site, No reported glycans. DR Proteomes; UP000008282; Genome. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-UniRule. DR GO; GO:0019031; C:viral envelope; IEA:UniProtKB-KW. DR GO; GO:0055036; C:virion membrane; IEA:UniProtKB-SubCell. DR GO; GO:0075513; P:caveolin-mediated endocytosis of virus by host cell; IEA:UniProtKB-KW. DR GO; GO:0039654; P:fusion of virus membrane with host endosome membrane; IEA:UniProtKB-KW. DR GO; GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-UniRule. DR HAMAP; MF_04075; HBV_HBSAG; 1. DR InterPro; IPR000349; HBV_HBSAG. DR Pfam; PF00695; vMSA; 1. PE 1: Evidence at protein level; KW Acetylation; Alternative initiation; Alternative splicing; KW Caveolin-mediated endocytosis of virus by host; KW Fusion of virus membrane with host endosomal membrane; KW Fusion of virus membrane with host membrane; Glycoprotein; KW Host-virus interaction; Lipoprotein; Membrane; Myristate; Transmembrane; KW Transmembrane helix; Viral attachment to host cell; Viral envelope protein; KW Viral penetration into host cytoplasm; Virion; Virus endocytosis by host; KW Virus entry into host cell. FT INIT_MET 1 FT /note="Removed; by host" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT CHAIN 2..389 FT /note="Large envelope protein" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT /id="PRO_0000319087" FT TOPO_DOM 2..242 FT /note="Intravirion; in internal conformation" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TOPO_DOM 2..170 FT /note="Virion surface; in external conformation" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TRANSMEM 171..191 FT /note="Helical; Name=TM1; Note=In external conformation" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TOPO_DOM 192..242 FT /note="Intravirion; in external conformation" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TRANSMEM 243..263 FT /note="Helical; Name=TM2" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TOPO_DOM 264..337 FT /note="Virion surface" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TRANSMEM 338..358 FT /note="Helical" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TOPO_DOM 359..364 FT /note="Intravirion" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TRANSMEM 365..387 FT /note="Helical; Name=TM3" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT TOPO_DOM 388..389 FT /note="Virion surface" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT REGION 1..54 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 2..163 FT /note="Pre-S" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT REGION 2..108 FT /note="Pre-S1" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT REGION 73..106 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 109..163 FT /note="Pre-S2" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT COMPBIAS 80..97 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT LIPID 2 FT /note="N-myristoyl glycine; by host" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT CARBOHYD 309 FT /note="N-linked (GlcNAc...) asparagine; by host" FT /evidence="ECO:0000255|HAMAP-Rule:MF_04075" FT VAR_SEQ 1..163 FT /note="Missing (in isoform S)" FT /evidence="ECO:0000305" FT /id="VSP_031410" SQ SEQUENCE 389 AA; 42661 MW; A39542B416E48F24 CRC64; MGQNLSTSNP LGFFPDHQLD PASRANTANP DWDFNPNKDT WPDANKDGAG AFGLGLTPPH GGLLGWSPQA QGILHTVPAN PPPASTNRQT GRQPTPLSPP LRDTHPQAVQ WNSTTFHQTL QDPRVRGLYF PAGGSSSGTV NPVPTTASPL SSIFSRIGDP VTNMENITSG FLGPLLVLQA GFFLLTRILT IPQSLDSWWT SLNFRGGTTV CLGQNSQSPT SNHSPTSCPP TCPGYRWMCL RGFIIFLFIL LLCLIFLLVL LEYQGMLHVC PLIPGTTTTS TGPCKTCTTP AQGNSMFPSC CCTKTSDGNC TCIPIPSSWA FAKYLWEWAS VRFSWLSLLV PFVQWFVGLS PTVWLSAIWM MWYWGPSLYS ILSPFLPLLP IFFCLWVYI //